23andMe Holding Co. ( ME) - Stock Earnings
Stock symbol ME is outdated, potentially delisted? Maybe it is available on other exchange?
ME Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -208.8 million USD | 64.0 million USD |
| 2024Q2 | -69.4 million USD | 40.4 million USD |
| 2024Q3 | -59.1 million USD | 44.1 million USD |
ME Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -217.5 million USD | 271.9 million USD |
| 2023 | -311.7 million USD | 299.5 million USD |
| 2024 | -666.7 million USD | 219.6 million USD |
ME
Price: $0.61
52 week price:
Earnings Per Share: -17.39 USD
P/E Ratio: -0.03
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.6 million
Market Capitalization: 13.3 million